‘Desperate’ Hep C patients importing medicines

Despite the PBS recommending a fourth antiviral treatment for hepatitis C at their July meeting, no listing date has been set, leaving some patients so desperate they are resorting to importing generic antiviral medicines.

Hepatitis Australia CEO Helen Tyrell says a total of four ground-breaking curative hepatitis C therapies have now received the green light for inclusion on the PBS, but so far no listing date has been confirmed for any of them.